In tumor-associated macrophages (TAMs), activation of AhR by Kyn contributes to a immunosuppressive phenotype by modulating the expression of tolerogenic molecules such as the ectonucleotidase CD39 (54). This evidence concerns the gene AHR and neoplasm.